Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Fragment-based design of targeted covalent inhibitors : the scope and limitation of linking approaches
ID
Kollár, Levente
(
Author
),
ID
Mihalovits, Levente M.
(
Author
),
ID
Bajusz, Dávid
(
Author
),
ID
Knez, Damijan
(
Author
),
ID
Simon, József
(
Author
),
ID
Balcomb, Blake H.
(
Author
),
ID
Fearon, Daren
(
Author
),
ID
Gobec, Stanislav
(
Author
),
ID
Keserü M., György
(
Author
)
PDF - Presentation file,
Download
(5,48 MB)
MD5: 4C5400440AEBD306FFBBC72477C0870F
URL - Source URL, Visit
https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202501108
Image galllery
Abstract
Linking of fragments in neighboring binding sites is one of the optimization strategies in fragment-based drug discovery, where additive or even more substantial bioactivity improvements can be realized. However, such efforts present a considerable challenge when one fragment binds covalently to the target protein, as small modifications can influence the correct positioning of the covalent warhead toward the targeted nucleophilic residue. Here, we present a case study of fragment linking that yielded single-digit micromolar, covalent inhibitors of the SARS-CoV-2 main protease, starting from fragments that were inactive in the biochemical assay. Using structural information from a recent, high-throughput crystallographic fragment screen, we show that the success of fragment linking in the design of targeted covalent inhibitors is heavily impacted by several factors, including the warhead type, the labeling chemistry, and even subtle changes in the designed linker. Notably, we observe that induced fit effects might override the original fragment orientations in the linked molecule, highlighting the need for reliable structure verification, especially in consecutive rounds of fragment elaboration.
Language:
English
Keywords:
3CLpro inhibitors
,
covalent inhibitors
,
fragment linking
,
fragment-based drug discovery
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2026
Number of pages:
Str. 1-16
Numbering:
Vol. 21, iss. 10, art. e202501108
PID:
20.500.12556/RUL-185268
UDC:
616.98-036.21:578.834
ISSN on article:
1860-7187
DOI:
10.1002/cmdc.202501108
COBISS.SI-ID:
281555459
Publication date in RUL:
30.07.2026
Views:
253
Downloads:
159
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ChemMedChem
Shortened title:
ChemMedChem
Publisher:
Wiley-VCH-Verl..
ISSN:
1860-7187
COBISS.SI-ID:
519053337
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
zaviralci 3CLpro
,
kovalentni zaviralci
,
povezovanje fragmentov
,
odkrivanje zdravil na osnovi fragmentov
,
SARS-CoV-2
,
farmacevtska kemija
Projects
Funder:
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Project number:
FK146063
Funder:
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Project number:
SNN135335
Funder:
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Project number:
2020-1.1.2-PIACI-KFI-2020-00039
Funder:
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Project number:
RRF-2.3.1-21-2022-00015
Funder:
Hungarian Academy of Sciences (NAP3.0) and Slovenian Research and Innovation Agency - ARIS
Project number:
BI-HU/21-22-003
Funder:
Other - Other funder or multiple funders
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back